Macrocure Ltd.

(MCUR) Trade

By |

Profile

Leap Therapeutics Inc is a biopharmaceutical company. The company is acquiring and developing novel therapeutics at the leading edge of cancer biology. Its programs are monoclonal antibodies that target key cellular pathways that enable cancer to grow and spread and specific mechanisms that activate the body's immune system to identify and attack cancer. Leap has two clinical stage programs: DKN-01 and TRX518. DKN-01 is a monoclonal antibody targeting Dickkopf-related protein 1, or DKK1, a protein that regulates important cell signaling pathways, known as the Wnt pathways. TRX518 is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor, or GITR, a receptor found on the surface of a wide range of immune cells.

Contact Information

Website: www.leaptx.com
Email: donsi@leaptx.com
Main Phone: +1 617 714-0360
Address: 47 Thorndike Street
Address 2: Suite B1-1
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02141

Issuer Information

Exchange: NSD
CEO: Christopher K. Mirabelli
Employees: 22
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 3.20 52 Wk Low 0.75
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 17,080,652.00 EPS (TTM) -0.54 PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.5 1.5 1.5 1.5
Low Target Price Estimate 1.5 1.5 1.5 1.5
Mean Target Price Estimate 1.5 1.5 1.5 1.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 10/27/15 10/27/15 10/27/15 10/27/15
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3